Ritlecitinib lower dose clinical trials

A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata

This study is looking into a new medicine called ritlecitinib for children aged 6 to 11 with severe alopecia areata, a condition that causes hair loss. It aims to see if the medicine is safe and helps hair regrow. Participants will take a capsule daily for 6 months.